相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Cyclooxygenase-2 Inhibitor: A Potential Combination Strategy With Immunotherapy in Cancer
Dan Pu et al.
FRONTIERS IN ONCOLOGY (2021)
The Limitless Future of RNA Therapeutics
Tulsi Ram Damase et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2021)
Upregulation of C/EBPα Inhibits Suppressive Activity of Myeloid Cells and Potentiates Antitumor Response in Mice and Patients with Cancer
Ayumi Hashimoto et al.
CLINICAL CANCER RESEARCH (2021)
MTL-CEBPA Combined with Immunotherapy or RFA Enhances Immunological Anti-Tumor Response in Preclinical Models
Kai-Wen Huang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Small activating RNAs lead the charge to turn up gene expression
Katie Kingwell
NATURE REVIEWS DRUG DISCOVERY (2021)
Identification of ARGLU1 as a potential therapeutic target for gastric cancer based on genome-wide functional screening data
Fangyuan Li et al.
EBIOMEDICINE (2021)
CCAAT enhancer-binding protein a suppresses proliferation, metastasis, and epithelial-mesenchymal transition of ovarian cancer cells via suppressing the Wnt/β-catenin signaling
Li-Mei Zhang et al.
NEOPLASMA (2021)
MTL-CEBPA, a Small Activating RNA Therapeutic Upregulating C/EBP-a, in Patients with Advanced Liver Cancer: A First-in-Human, Multicenter, Open-Label, Phase I Trial
Debashis Sarker et al.
CLINICAL CANCER RESEARCH (2020)
Delivery of Oligonucleotides to the Liver with GalNAc: From Research to Registered Therapeutic Drug
Alexandre J. Debacker et al.
MOLECULAR THERAPY (2020)
Fatty acid transport protein 2 reprograms neutrophils in cancer
Filippo Veglia et al.
NATURE (2019)
Mechanisms involved in the activation of C/EBPα by small activating RNA in hepatocellular carcinoma
Xiaoyang Zhao et al.
ONCOGENE (2019)
Targeted Delivery of C/EBPα-saRNA by RNA Aptamers Shows Anti-tumor Effects in a Mouse Model of Advanced PDAC
Sorah Yoon et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2019)
MTLCEBPA, a drug candidate for hepatocellular-carcinoma enhances efficacy of Sorafenib
Nagy A. Habib et al.
CANCER RESEARCH (2019)
Developing small activating RNA as a therapeutic: current challenges and promises
Albert Kwok et al.
THERAPEUTIC DELIVERY (2019)
Targeting tumor-infiltrating Ly6G+ myeloid cells improves sorafenib efficacy in mouse orthotopic hepatocellular carcinoma
Chun-Jung Chang et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
SaRNA-mediated activation of TRPV5 reduces renal calcium oxalate deposition in rat via decreasing urinary calcium excretion
Tao Zeng et al.
UROLITHIASIS (2018)
saRNAdb: Resource of Small Activating RNAs for Up-regulating the Gene Expression
Showkat Ahmad Dar et al.
JOURNAL OF MOLECULAR BIOLOGY (2018)
Gene activation of CEBPA using saRNA: preclinical studies of the first in human saRNA drug candidate for liver cancer
Vikash Reebye et al.
ONCOGENE (2018)
Myeloid-Derived Suppressor Cells Hinder the Anti-Cancer Activity of Immune Checkpoint Inhibitors
Rebekka Weber et al.
FRONTIERS IN IMMUNOLOGY (2018)
Preliminary results of a first-in-human, first-in-class phase I study of MTL-CEBPA, a small activating RNA (saRNA) targeting the transcription factor C/EBP-α in patients with advanced liver cancer.
Debashis Sarker et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Development and Mechanism of Small Activating RNA Targeting CEBPA, a Novel Therapeutic in Clinical Trials for Liver Cancer
Jon Voutila et al.
MOLECULAR THERAPY (2017)
Enhanced wild-type p53 expression by small activating RNA dsP53-285 induces cell cycle arrest and apoptosis in pheochromocytoma cell line PC12
Dengqiang Lin et al.
ONCOLOGY REPORTS (2017)
Dual negative roles of C/EBPα in the expansion and pro-tumor functions of MDSCs
John R. Mackert et al.
SCIENTIFIC REPORTS (2017)
C/EBP alpha Suppresses Lung Adenocarcinoma Cell Invasion and Migration by Inhibiting beta-Catenin
Jinchang Lu et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
Tumor-selective lipopolyplex encapsulated small active RNA hampers colorectal cancer growth in vitro and in orthotopic murine
Lu-Lu Wang et al.
BIOMATERIALS (2017)
Expression and regulation of C/EBPα in normal myelopoiesis and in malignant transformation
Roberto Avellino et al.
BLOOD (2017)
Evolutionary acquisition of promoterassociated non-coding RNA (pancRNA) repertoires diversifies species-dependent gene activation mechanisms in mammals
Masahiro Uesaka et al.
BMC GENOMICS (2017)
saRNA-guided Ago2 targets the RITA complex to promoters to stimulate transcription
Victoria Portnoy et al.
CELL RESEARCH (2016)
Tumor-Associated Neutrophils Recruit Macrophages and T-Regulatory Cells to Promote Progression of Hepatocellular Carcinoma and Resistance to Sorafenib
Shao-Lai Zhou et al.
GASTROENTEROLOGY (2016)
Demystifying the mechanistic and functional aspects of p21 gene activation with double-stranded RNAs in human cancer cells
Huan-Lei Wu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2016)
Targeted Delivery of C/EBPα -saRNA by Pancreatic Ductal Adenocarcinoma-specific RNA Aptamers Inhibits Tumor Growth In Vivo
Sorah Yoon et al.
MOLECULAR THERAPY (2016)
Small activating RNA binds to the genomic target site in a seed-region-dependent manner
Xing Meng et al.
NUCLEIC ACIDS RESEARCH (2016)
Management of hepatocellular carcinoma: An overview of major findings from meta-analyses
Xingshun Qi et al.
ONCOTARGET (2016)
RNA activation of haploinsufficient Foxg1 gene in murine neocortex
Cristina Fimiani et al.
SCIENTIFIC REPORTS (2016)
Small-Activating RNA Can Change Nucleosome Positioning in Human Fibroblasts
Bin Wang et al.
JOURNAL OF BIOMOLECULAR SCREENING (2016)
Deregulation of the endogenous C/EBPβ LIP isoform predisposes to tumorigenesis
Valerie Begay et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2015)
A Novel RNA Oligonucleotide Improves Liver Function and Inhibits Liver Carcinogenesis In Vivo
Vikash Reebye et al.
HEPATOLOGY (2014)
Transcriptional Regulation and Its Misregulation in Disease
Tong Ihn Lee et al.
CELL (2013)
Promoter-targeted double-stranded small RNAs activate PAWR gene expression in human cancer cells
Kai Yang et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2013)
CCAAT/Enhancer-Binding Protein-α Suppresses Lung Tumor Development in Mice through the p38α MAP Kinase Pathway
Atsuyasu Sato et al.
PLOS ONE (2013)
Promoter-associated small double-stranded RNA interacts with heterogeneous nuclear ribonucleoprotein A2/B1 to induce transcriptional activation
Jia Hu et al.
BIOCHEMICAL JOURNAL (2012)
Intravesical Delivery of Small Activating RNA Formulated into Lipid Nanoparticles Inhibits Orthotopic Bladder Tumor Growth
Moo Rim Kang et al.
CANCER RESEARCH (2012)
Inhibition of natural antisense transcripts in vivo results in gene-specific transcriptional upregulation
Farzaneh Modarresi et al.
NATURE BIOTECHNOLOGY (2012)
Upregulation of Cyclin B1 by miRNA and its implications in cancer
Vera Huang et al.
NUCLEIC ACIDS RESEARCH (2012)
Up-regulation of p21WAF1/CIP1 by small activating RNA inhibits the in vitro and in vivo growth of pancreatic cancer cells
Zhiping Zhang et al.
TUMORI JOURNAL (2012)
Formulation of Small Activating RNA Into Lipidoid Nanoparticles Inhibits Xenograft Prostate Tumor Growth by Inducing p21 Expression
Robert F. Place et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2012)
Small RNA and transcriptional upregulation
Victoria Portnoy et al.
WILEY INTERDISCIPLINARY REVIEWS-RNA (2011)
p21WAF1/CIP1 gene transcriptional activation exerts cell growth inhibition and enhances chemosensitivity to cisplatin in lung carcinoma cell
Junxia Wei et al.
BMC CANCER (2010)
Double strand RNA-guided endogeneous E-cadherin up-regulation induces the apoptosis and inhibits proliferation of breast carcinoma cells in vitro and in vivo
Wei Junxia et al.
CANCER SCIENCE (2010)
Defining Features and Exploring Chemical Modifications to Manipulate RNAa Activity
Robert F. Place et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2010)
Involvement of argonaute proteins in gene silencing and activation by RNAs complementary to a non-coding transcript at the progesterone receptor promoter
Yongjun Chu et al.
NUCLEIC ACIDS RESEARCH (2010)
RNAa Is Conserved in Mammalian Cells
Vera Huang et al.
PLOS ONE (2010)
Genetic causes of hypercalciuric nephrolithiasis
Michael J. Stechman et al.
PEDIATRIC NEPHROLOGY (2009)
Ultraconservation identifies a small subset of extremely constrained developmental enhancers
Axel Visel et al.
NATURE GENETICS (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Genetic ablation of CCAAT/Enhancer binding protein α in epidermis reveals its role in suppression of epithelial tumorigenesis
Kari D. Loomis et al.
CANCER RESEARCH (2007)
Tumor suppressor activity of CCAAT/enhancer binding protein α is epigenetically down-regulated in head and neck squamous cell carcinoma
Kristi L. Bennett et al.
CANCER RESEARCH (2007)
Activating gene expression in mammalian cells with promoter-targeted duplex RNAs
Bethany A. Janowski et al.
NATURE CHEMICAL BIOLOGY (2007)
In vivo enhancer analysis of human conserved non-coding sequences
Len A. Pennacchio et al.
NATURE (2006)
Small dsRNAs induce transcriptional activation in human cells
Long-Cheng Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Diminished expression of transcription factors nuclear factor κB and CCAAT/enhancer binding protein underlies a novel tumor evasion mechanism affecting macrophages of mammary tumor-bearing mice.
M Torroella-Kouri et al.
CANCER RESEARCH (2005)
Modulation of hepatitis C virus RNA abundance by a liver-specific microRNA
CL Jopling et al.
SCIENCE (2005)
A small modulatory dsRNA specifies the fate of adult neural stem cells
T Kuwabara et al.
CELL (2004)
Host cyclooxygenase-2 modulates carcinoma growth
CS Williams et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)